Sarah Barrin

1.5k total citations · 2 hit papers
10 papers, 974 citations indexed

About

Sarah Barrin is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Sarah Barrin has authored 10 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Sarah Barrin's work include Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (4 papers) and T-cell and B-cell Immunology (4 papers). Sarah Barrin is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (4 papers) and T-cell and B-cell Immunology (4 papers). Sarah Barrin collaborates with scholars based in France, Germany and United Kingdom. Sarah Barrin's co-authors include Emmanuel Donnadieu, Chahrazade Kantari‐Mimoun, Lene Vimeux, Marco Alifano, Diane Damotte, Nadège Bercovici, Audrey Lupo, Elisa Peranzoni, Fabienne Régnier and Jean Lemoine and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Oncogene.

In The Last Decade

Sarah Barrin

9 papers receiving 968 citations

Hit Papers

Macrophages impede CD8 T ... 2018 2026 2020 2023 2018 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Barrin France 7 624 602 224 130 85 10 974
Chahrazade Kantari‐Mimoun France 10 680 1.1× 766 1.3× 388 1.7× 140 1.1× 111 1.3× 11 1.3k
Miriam R. Fein United States 5 492 0.8× 769 1.3× 336 1.5× 210 1.6× 98 1.2× 8 1.2k
Aviad Ben‐Shmuel Israel 10 385 0.6× 354 0.6× 249 1.1× 62 0.5× 75 0.9× 12 716
Sheila Spada United States 11 378 0.6× 369 0.6× 370 1.7× 90 0.7× 92 1.1× 21 835
Yumi Kinugasa‐Katayama Japan 5 325 0.5× 577 1.0× 263 1.2× 138 1.1× 76 0.9× 7 898
Anna Passarelli Italy 14 426 0.7× 365 0.6× 400 1.8× 82 0.6× 113 1.3× 34 880
Elise Lavergne France 14 262 0.4× 263 0.4× 248 1.1× 71 0.5× 61 0.7× 16 665
Jiemiao Hu United States 15 327 0.5× 379 0.6× 172 0.8× 62 0.5× 80 0.9× 32 657
Silvia Mele United Kingdom 13 300 0.5× 208 0.3× 257 1.1× 71 0.5× 44 0.5× 23 681
Dorota E. Kuczek Denmark 4 316 0.5× 233 0.4× 119 0.5× 110 0.8× 37 0.4× 5 517

Countries citing papers authored by Sarah Barrin

Since Specialization
Citations

This map shows the geographic impact of Sarah Barrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Barrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Barrin more than expected).

Fields of papers citing papers by Sarah Barrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Barrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Barrin. The network helps show where Sarah Barrin may publish in the future.

Co-authorship network of co-authors of Sarah Barrin

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Barrin. A scholar is included among the top collaborators of Sarah Barrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Barrin. Sarah Barrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Barrin, Sarah, et al.. (2023). Live Imaging of CAR T Cell Ca2+ Signals in Tumor Slices Using Confocal Microscopy. Methods in molecular biology. 2654. 453–462. 3 indexed citations
3.
Kantari‐Mimoun, Chahrazade, Sarah Barrin, Lene Vimeux, et al.. (2021). CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1. Cancer Immunology Research. 9(12). 1425–1438. 51 indexed citations
4.
Nicolás‐Boluda, Alba, Javier Vaquero, Lene Vimeux, et al.. (2021). Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. eLife. 10. 215 indexed citations breakdown →
5.
Kantari‐Mimoun, Chahrazade, Sarah Barrin, Lene Vimeux, et al.. (2021). CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1.. PubMed. 9(12). 1425–1438. 41 indexed citations
6.
Barrin, Sarah, et al.. (2020). Extracellular Release of Antigen by Dendritic Cell Regurgitation Promotes B Cell Activation through NF-κB/cRel. The Journal of Immunology. 205(3). 608–618. 2 indexed citations
7.
Saux, Olivia Le, et al.. (2020). Neoadjuvant immune checkpoint inhibitors in cancer, current state of the art. Critical Reviews in Oncology/Hematology. 157. 103172–103172. 7 indexed citations
8.
Peranzoni, Elisa, Jean Lemoine, Lene Vimeux, et al.. (2018). Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment. Proceedings of the National Academy of Sciences. 115(17). E4041–E4050. 631 indexed citations breakdown →
9.
Peranzoni, Elisa, Houcine Bougherara, Sarah Barrin, et al.. (2017). <em>Ex Vivo</em> Imaging of Resident CD8 T Lymphocytes in Human Lung Tumor Slices Using Confocal Microscopy. Journal of Visualized Experiments. 16 indexed citations
10.
Ardin, Maude, Annette Weninger, Sarah Barrin, et al.. (2017). Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing. Oncogene. 36(43). 6041–6048. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026